Today, Stan Wong commented about whether ORLY-Q, MCK-N, MA-N, SBUX-Q, QSR-T, DIS-N, CSH.UN-T, AAPL-Q, MSFT-Q, MSFT-Q, ZAG-T, PFE-N, V-N, LVMUY-OTC, IXG-N, IXJ-N, XLV-N, ABT-N, T-N, ZWK-T, ABX-T, VALT-T, CGL-T, XGD-T, AAPL-Q, FEZ-N, XEI-T, VDY-T, ZRE-T, AGG-N, XAGH-T are stocks to buy or sell.
74% government bonds in Canada, rest in investment-grade corporate. Likes bonds at this stage, with interest rates calming and starting to come down. There will be small upticks pushing down the price of bonds, but up 6.6% in last 3 months. With yield plus potential for capital appreciation, makes sense to have as core part of your portfolio. Yield is 3.5%.
Hit record high earlier today. Makes sense especially with exposure to AI space. Cloud business is growing, subscriptions keep the money flowing. Not cheap now at 33.5x, growing at 15x, 2x PEG. Forward price to sales a bit high at 11x.
In all the right spaces and doing the right things. Hold. Be careful adding, as tech did so well last year.
Disappointing, to say the least. Spent a lot of $$ on streaming content, which has been troublesome, not seeing a profit. Subscriptions have wavered. Plans to reduce spending on content, but how will this impact subscribers? Now above 200-day MA. Wait and see. Long-term iconic brand, more wealthy travellers to parks. Studio fatigue.
Grown revenue by 10% annualized last 5 years. Second-largest digital payments company after Visa. Over 210 countries, 150 currencies. Solid consumer spending that's growing. Travel demand, higher cross-border volumes.
Extensive global network. Very strong brand recognition, great technology gives it strong competitive advantages to protect market share. Industry has plenty of runway for growth. Tollbooth. Share buybacks, raised dividend 16%. Earnings growth looks to be 17% or more for several years. Reasonable price. Great core name. Yield is 0.6%.
About $305B USD expected revenue for 2024. Largest customers are CVS and WMT. Middleman between end-retail pharmacies and medical product companies. Operates in a virtual triopoloy. Long term, demographics will lead to greater spending.
Increased share buybacks. Beat topline and bottom line expectations on latest quarter, raised guidance. Chart's trending higher, it's the best. Outpacing S&P 500 since early 2019. Earnings growth rate of about 10%. Solid healthcare name. Yield is 0.5%.
Largest in its space. $17B USD forecast 2024 revenue. Grew revenue last 5 years by 10.5%. Long-term tailwinds, as growing need for maintenance and repairs due to aging US automotive fleet. With an eye to interest rates and the economy, people have been holding onto their cars for longer. Resilient business. Increased share buybacks. He expects 12% EPS growth rate for next few years. No dividend.
(Analysts’ price target is $1036.26)
#1 in the world. Digital trend will continue. Fantastic brand recognition and strategic partnerships. 14-15% EPS growth rate for next several years.
See his Top Picks.